Epidermal Growth Factor Receptor (EGFR) Mutations
1 competing product in clinical development for Epidermal Growth Factor Receptor (EGFR) Mutations.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| radio-labeled naquotinib + naquotinib | Astellas Pharma | Phase 1 | Withdrawn | 21 |